Interferon alfa-nl | |
---|---|
Trade Name | Wellferon |
Orphan Indication | Human papillomavirus in patients with severe resistant/recurrent respiratory (laryngeal) papillomatosis |
USA Market Approval | USA |
USA Designation Date | 1987-10-16 00:00:00 |
Sponsor | Glaxo Wellcome Inc.;5 Moore Drive;Research Triangle Park, North Carolina, 27709 |